Atenção!


O atendimento às questões referentes ao Repositório Institucional será interrompido entre os dias 20 de dezembro de 2025 a 4 de janeiro de 2026.

Pedimos a sua compreensão e aproveitamos para desejar boas festas!

Logo do repositório

Salivary Metabolomics in Patients with Long COVID-19 Infection

dc.contributor.authorMachado, Luiz [UNESP]
dc.contributor.authorPrudente, Robson [UNESP]
dc.contributor.authorFranco, Estefânia [UNESP]
dc.contributor.authorGatto, Mariana [UNESP]
dc.contributor.authorMota, Gustavo [UNESP]
dc.contributor.authorPagan, Luana [UNESP]
dc.contributor.authorBrizola, Luís [UNESP]
dc.contributor.authordos Santos, Maércio [UNESP]
dc.contributor.authorCunha, Thulio
dc.contributor.authorSabino-Silva, Robinson
dc.contributor.authorGoulart, Luiz
dc.contributor.authorMartins, Mario
dc.contributor.authorSantos, Paula
dc.contributor.authorMaia, Larissa
dc.contributor.authorAlbuquerque, André
dc.contributor.authorFerreira, Eloara
dc.contributor.authorBaldi, Bruno
dc.contributor.authorOkoshi, Marina [UNESP]
dc.contributor.authorTanni, Suzana [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionUniversity of Uberlandia
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2025-04-29T19:14:24Z
dc.date.issued2024-11-01
dc.description.abstractBackground: Long COVID-19 has been characterized by the presence of symptoms lasting longer than 4 weeks after the acute infection. The pathophysiology of clinical manifestations still lacks knowledge. Objective: The objective of this paper was to evaluate metabolite abundance in the saliva of long COVID patients 60 days after hospital discharge. Methods: A convenience sample was composed of 30 post-discharge patients with long COVID and seven non-COVID-19 controls. All COVID-19 patients were evaluated by demographic characteristics, spirometry, 6 min walk test (6mWT), Saint George Respiratory Questionnaire (SGRQ), and body composition. Metabolomics was performed on saliva. Results: The long COVID-19 patients were 60.4 ± 14.3 years-old, and 66% male. Their lean body mass was 30.7 ± 7.3 kg and fat mass, 34.4 ± 13.7 kg. Spirometry evaluation showed forced vital capacity (FVC) of 3.84 ± 0.97 L with 96.0 ± 14.0% of the predicted value, and forced expiratory volume in the first second (FEV1) of 3.11 ± 0.83 L with 98.0 ± 16.0 of the predicted value. The long COVID-19 patients had reduced maximal inspiratory (90.1 ± 31.6 cmH2O) and maximal expiratory (97.3 ± 31.0 cmH2O) pressures. SGRQ showed domain symptoms of 32.3 ± 15.2, domain activities of 41.9 ± 25.6, and domain impact 13.7 ± 11.4, with a mean of 24.3 ± 14.9%. Physical capacity measured by distance covered in the 6mWT was 418.2 ± 130 m with a 73.3% (22.3–98.1) predictive value. The control group consisted of 44.1 ± 10.7-year-old men with a body mass index of 26.5 ± 1.66 Kg/m2. Metabolomics revealed 19 differentially expressed metabolites; expression was lower in 16 metabolites, and 2 metabolites were absent in the COVID-19 patients compared to controls. Calenduloside G methyl ester (p = 0.03), Gly Pro Lys (p = 0.0001), and creatine (p = 0.0001) expressions were lower in patients than controls. Conclusions: Long COVID-19 patients present less abundance of calenduloside G methyl ester, Gly Pro Lys, and creatine in saliva than healthy controls. Lower creatine abundance may be related to reduced physical capacity and fatigueen
dc.description.affiliationBotucatu Medical School São Paulo State University
dc.description.affiliationFaculty of Medicine of the Federal University of Uberlandia
dc.description.affiliationDepartment of Pneumology University of São Paulo
dc.description.affiliationDepartment of the Federal University of São Paulo
dc.description.affiliationUnespBotucatu Medical School São Paulo State University
dc.identifierhttp://dx.doi.org/10.3390/metabo14110598
dc.identifier.citationMetabolites, v. 14, n. 11, 2024.
dc.identifier.doi10.3390/metabo14110598
dc.identifier.issn2218-1989
dc.identifier.scopus2-s2.0-85210557153
dc.identifier.urihttps://hdl.handle.net/11449/302380
dc.language.isoeng
dc.relation.ispartofMetabolites
dc.sourceScopus
dc.subjectCOVID-19
dc.subjectfunctional capacity
dc.subjectmetabolomics
dc.subjectpost-COVID-19
dc.titleSalivary Metabolomics in Patients with Long COVID-19 Infectionen
dc.typeArtigopt
dspace.entity.typePublication
relation.isOrgUnitOfPublicationa3cdb24b-db92-40d9-b3af-2eacecf9f2ba
relation.isOrgUnitOfPublication.latestForDiscoverya3cdb24b-db92-40d9-b3af-2eacecf9f2ba
unesp.author.orcid0000-0002-1975-879X[1]
unesp.author.orcid0000-0003-1175-1435[2]
unesp.author.orcid0000-0002-3115-0795[4]
unesp.author.orcid0000-0001-8103-3338[5]
unesp.author.orcid0000-0002-1803-4861[11]
unesp.author.orcid0000-0001-7381-2788[12]
unesp.author.orcid0000-0003-2650-6635[13]
unesp.author.orcid0000-0001-7283-1020[14]
unesp.author.orcid0000-0002-3291-6473[16]
unesp.author.orcid0000-0002-9609-5117[17]
unesp.author.orcid0000-0002-2587-2759[19]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt

Arquivos